These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29746430)

  • 1. Vascular Injury After Deoxycholic Acid Injection.
    McKay C; Price C; Pruett L
    Dermatol Surg; 2019 Feb; 45(2):306-309. PubMed ID: 29746430
    [No Abstract]   [Full Text] [Related]  

  • 2. Permanent Cutaneous Adverse Events After Injection With Deoxycholic Acid.
    Ramirez MR; Marinaro RE; Warthan ML; Burton CS
    Dermatol Surg; 2019 Nov; 45(11):1432-1434. PubMed ID: 30672855
    [No Abstract]   [Full Text] [Related]  

  • 3. Safe and Successful Administration of Deoxycholic Acid in a Patient With Chronic Active Liver Disease.
    Eilers SE; Torbeck R; Krishnasamy S; Khorasani H
    Dermatol Surg; 2020 Sep; 46(9):1240-1242. PubMed ID: 32870612
    [No Abstract]   [Full Text] [Related]  

  • 4. Real-World Experience With 100 Consecutive Patients Undergoing Neck Contouring With ATX-101 (Deoxycholic Acid): An Updated Report With A 2-Year Analysis.
    Shridharani SM
    Dermatol Surg; 2019 Oct; 45(10):1285-1293. PubMed ID: 30789506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alopecia Following Deoxycholic Acid Treatment for Submental Adiposity.
    Sebaratnam DF; Wong XL; Kim L; Cheung K
    JAMA Facial Plast Surg; 2019 Dec; 21(6):571-572. PubMed ID: 31436782
    [No Abstract]   [Full Text] [Related]  

  • 6. Submental Alopecia at Deoxycholic Acid Injection Site.
    Grady B; Porphirio F; Rokhsar C
    Dermatol Surg; 2017 Aug; 43(8):1105-1108. PubMed ID: 28291068
    [No Abstract]   [Full Text] [Related]  

  • 7. Recurrent Xanthelasmas Treated With Intralesional Deoxycholic Acid.
    Patel J; Ranjit-Reeves R; Woodward J
    Dermatol Surg; 2020 Jun; 46(6):847-848. PubMed ID: 30893171
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy and Safety of ATX-101 by Treatment Session: Pooled Analysis of Data From the Phase 3 REFINE Trials.
    Dayan SH; Schlessinger J; Beer K; Donofrio LM; Jones DH; Humphrey S; Carruthers J; Lizzul PF; Gross TM; Beddingfield FC; Somogyi C
    Aesthet Surg J; 2018 Aug; 38(9):998-1010. PubMed ID: 29401213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement in Jowl Fat following ATX-101 Treatment: Results from a Single-Site Study.
    Shridharani SM
    Plast Reconstr Surg; 2020 Apr; 145(4):929-935. PubMed ID: 32221205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of injectable deoxycholic acid for submental fat reduction: a systematic review and meta-analysis of randomized controlled trials.
    Cunha KS; Lima F; Cardoso RM
    Expert Rev Clin Pharmacol; 2021 Mar; 14(3):383-397. PubMed ID: 33523775
    [No Abstract]   [Full Text] [Related]  

  • 11. Intralesional Deoxycholic Acid as Neoadjuvant Treatment of a Large Lipoma.
    Dubin DP; Farberg AS; Lin MJ; Khorasani H
    Dermatol Surg; 2020 May; 46(5):715-717. PubMed ID: 31318828
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and safety of ATX-101 as a treatment for submental fullness: A retrospective analysis of two aesthetic practices.
    Zarbafian M; Karavan M; Greene R; Fabi SG
    J Cosmet Dermatol; 2020 Jun; 19(6):1328-1332. PubMed ID: 31553141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intralesional Deoxycholic Acid Treatment for Fibrofatty Residua of Involuted Infantile Hemangiomas: A Novel Therapeutic Approach.
    Cardis MA; DeKlotz CMC
    JAMA Dermatol; 2018 Jun; 154(6):735-737. PubMed ID: 29801031
    [No Abstract]   [Full Text] [Related]  

  • 14. A Cautionary Tale: A Vascular Event With Deoxycholic Acid Injection.
    Riswold K; Flynn V
    Dermatol Surg; 2018 Jun; 44(6):887-889. PubMed ID: 29016547
    [No Abstract]   [Full Text] [Related]  

  • 15. Current Trends in Management of Submental Liposis: A Pooled Analysis and Survey.
    Patel S; Kridel R
    JAMA Facial Plast Surg; 2018 May; 20(3):202-206. PubMed ID: 29049615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Future Applications of Deoxycholic Acid in Body Contouring.
    Sykes JM; Allak A; Klink B
    J Drugs Dermatol; 2017 Jan; 16(1):43-46. PubMed ID: 28095531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marginal Mandibular Versus Pseudo-Marginal Mandibular Nerve Injury With Submandibular Deoxycholic Acid Injection.
    Sorenson E; Chesnut C
    Dermatol Surg; 2018 May; 44(5):733-735. PubMed ID: 28858928
    [No Abstract]   [Full Text] [Related]  

  • 18. Deoxycholic acid (Kybella) for double chin.
    Med Lett Drugs Ther; 2015 Dec; 57(1483):165-6. PubMed ID: 26633685
    [No Abstract]   [Full Text] [Related]  

  • 19. Intralesional phosphatidylcholine and sodium deoxycholate: a possible treatment option for nevus lipomatosus superficialis.
    Kim HS; Park YM; Kim HO; Lee JY
    Pediatr Dermatol; 2012; 29(1):119-21. PubMed ID: 22150229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deoxycholic Acid: A Review in Submental Fat Contouring.
    Deeks ED
    Am J Clin Dermatol; 2016 Dec; 17(6):701-707. PubMed ID: 27785706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.